{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:20:23Z","timestamp":1787505623899,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU23-08-00229"],"award-info":[{"award-number":["NU23-08-00229"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpba.2025.116877","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:06:33Z","timestamp":1744398393000},"page":"116877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Non-invasive therapeutic drug monitoring: LC-MS validation for lamotrigine quantification in dried blood spot and oral fluid\/saliva"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-8711","authenticated-orcid":false,"given":"Marta","family":"Pelcov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2236-8615","authenticated-orcid":false,"given":"Vikt\u00f3ria","family":"\u010eur\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8610-5601","authenticated-orcid":false,"given":"Pavel","family":"\u0160mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-9056","authenticated-orcid":false,"given":"Ond\u0159ej","family":"Str\u00fd\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"\u0160tolcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Pe\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3426-6117","authenticated-orcid":false,"given":"Zden\u011bk","family":"Glatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"\u0160i\u0161t\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ju\u0159ica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116877_bib1","unstructured":"World.Health Organization, Epilepsy: a public health imperative, 2019."},{"issue":"7","key":"10.1016\/j.jpba.2025.116877_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jpba.2025.116877_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1528-1167.2007.01274.x","article-title":"Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (the COMPASS study)","volume":"49","author":"Tompson","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpba.2025.116877_bib4","unstructured":"UptoDate. Inc., Lamotrigine: Drug information, 2024."},{"issue":"08","key":"10.1016\/j.jpba.2025.116877_bib5","first-page":"517","article-title":"Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers","volume":"57","author":"Incecayir","year":"2007","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"10.1016\/j.jpba.2025.116877_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","article-title":"Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls","volume":"31","author":"Edelbroek","year":"2009","journal-title":"Ther. Drug. Monit."},{"issue":"23","key":"10.1016\/j.jpba.2025.116877_bib7","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1007\/s00216-015-8887-8","article-title":"Personalized monitoring of therapeutic salicylic acid in dried blood spots using a three-layer setup and desorption electrospray ionization mass spectrometry","volume":"407","author":"Siebenhaar","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2025.116877_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","author":"Zwart","year":"2018","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.116877_bib9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00228-019-02637-w","article-title":"Dried blood spot testing for estimation of renal function and analysis of metformin and sitagliptin concentrations in diabetic patients: a cross-sectional study","volume":"75","author":"Scherf-Clavel","year":"2019","journal-title":"Eur. J. Clin. Pharm."},{"issue":"5","key":"10.1016\/j.jpba.2025.116877_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ejhpharm-2022-003589","article-title":"Analytical and clinical validation of an LC-MS\/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots","volume":"31","author":"Besten-Bertholee","year":"2024","journal-title":"Eur. J. Hosp. Pharm."},{"issue":"3","key":"10.1016\/j.jpba.2025.116877_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FTD.0000000000000890","article-title":"Therapeutic Drug Monitoring of Lamotrigine, Lacosamide, and Levetiracetam in Dried Capillary Blood-Determination of Conversion Factors for Serum-Based Reference Ranges","volume":"43","author":"Klimpel","year":"2021","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2025.116877_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchromb.2017.11.005","article-title":"Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation","volume":"1072","author":"Linder","year":"2018","journal-title":"J. Chrom. B"},{"issue":"3","key":"10.1016\/j.jpba.2025.116877_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bcpt.13269","article-title":"Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs","volume":"125","author":"Min","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"449","key":"10.1016\/j.jpba.2025.116877_bib14","first-page":"1","article-title":"An LC-MS\/MS Method for Quantification of Lamotrigine and Its Main Metabolite in Dried Blood Spots","volume":"17","author":"Milosheska","year":"2024","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.jpba.2025.116877_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinbiochem.2019.09.009","article-title":"Comparison of plasma, saliva, and hair lamotrigine concentrations","volume":"74","author":"Kuczynska","year":"2019","journal-title":"Clin. Biochem"},{"issue":"4","key":"10.1016\/j.jpba.2025.116877_bib16","article-title":"Can the serum concentration of Lamotrigine be accurately predicted from the saliva concentration in pediatric patients?","volume":"33","author":"Fleming","year":"2011","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.jpba.2025.116877_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/FTD.0000000000000396","article-title":"Comparison of Plasma, Saliva, and Hair Levetiracetam Concentrations","volume":"39","author":"Kara\u015b-Ruszczyk","year":"2017","journal-title":"Ther. Drug Monit."},{"issue":"10","key":"10.1016\/j.jpba.2025.116877_bib18","first-page":"599","article-title":"A sensitive and selective HPLC method for estimation of lamotrigine in human plasma and saliva: application to plasma-saliva correlation in epileptic patients","volume":"60","author":"Mallayasamy","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jpba.2025.116877_bib19","article-title":"The utility of saliva for therapeutic drug monitoring of lamotrigine, in a pediatric population","volume":"46","author":"Malone","year":"2005","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.jpba.2025.116877_bib20","article-title":"Correlation of lamotrigine concentrations between serum and saliva","volume":"22","author":"Ryan","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.jpba.2025.116877_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00007691-200010000-00003","article-title":"Saliva and serum concentration of lamotrigine in patients with epilepsy","volume":"22","author":"Tsiropoulos","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2025.116877_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.microc.2016.09.007","article-title":"Determination of lamotrigine in human plasma and saliva using microextraction by packed sorbent and high performance liquid chromatography-diode array detection: An innovative bioanalytical tool for therapeutic drug monitoring","volume":"130","author":"Ventura","year":"2017","journal-title":"Microchem. J."},{"key":"10.1016\/j.jpba.2025.116877_bib23","article-title":"The correlation of lamotrigine concentrations between saliva and serum in children with epilepsy","volume":"27","author":"Zhang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpba.2025.116877_bib24","unstructured":"I.H. Guideline, Bioanalytical method validation and study sample analysis M10, ICH Harmonised Guideline: Geneva, Switzerland (2022)."},{"issue":"8","key":"10.1016\/j.jpba.2025.116877_bib25","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4155\/bio.10.103","article-title":"The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs","volume":"2","author":"Denniff","year":"2010","journal-title":"Bioanalysis"},{"issue":"16","key":"10.1016\/j.jpba.2025.116877_bib26","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4155\/bio.13.156","article-title":"Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions","volume":"5","author":"De Kesel","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.116877_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2016.01.030","article-title":"Opening the toolbox of alternative sampling strategies in clinical routine: A key-role for (LC-)MS\/MS","volume":"84","author":"Velghe","year":"2016","journal-title":"Trends Anal. Chem."},{"issue":"1-02","key":"10.1016\/j.jpba.2025.116877_bib28","article-title":"Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.jpba.2025.116877_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00003088-199630060-00003","article-title":"Measurement and analysis of unbound drug concentrations","volume":"30","author":"Wright","year":"1996","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.116877_bib30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2020.00340","article-title":"Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients","volume":"11","author":"Sheng","year":"2020","journal-title":"Front. Pharm."},{"issue":"16","key":"10.1016\/j.jpba.2025.116877_bib31","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4155\/bio.15.99","article-title":"A LC\u2013MS\/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS","volume":"7","author":"Linder","year":"2015","journal-title":"Bioanalysis"},{"issue":"9","key":"10.1016\/j.jpba.2025.116877_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5130","article-title":"Development and validation of an LC\u2013MS\/MS method for relevant drugs in epilepsy patients using dried blood spots","volume":"35","author":"M\u00f6ller","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2025.116877_bib33","article-title":"Statistics Corner: A Guide to Appropriate Use of Correlation Coefficient in Medical Research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med. J."},{"issue":"1","key":"10.1016\/j.jpba.2025.116877_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/875647939000600106","article-title":"Interpretation of the correlation coefficient: a basic review","volume":"6","author":"Taylor","year":"1990","journal-title":"J. Diagn. Med. Sonogr."},{"issue":"5","key":"10.1016\/j.jpba.2025.116877_bib35","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation Coefficients: Appropriate Use and Interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth. Analg."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:47:08Z","timestamp":1778539628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"alternative-id":["S0731708525002183"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116877","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive therapeutic drug monitoring: LC-MS validation for lamotrigine quantification in dried blood spot and oral fluid\/saliva","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116877"}}